RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 12-22
  • Express Scripts drops Gilead hep C drugs for cheaper AbbVie rival

    The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc's treatments after trying for nearly a year to...
  • Gilead shares plunge after Express Scripts spurns its $1,000 hepatitis C pill

    Gilead Sciences Inc., already under fire for the high costs of its hepatitis C drugs, took another hit Monday when the nation's largest manager of pharmacy benefits struck an exclusive deal with a rival drugmaker. Express Scripts Holding Co. said Monday...
  • High-dose flu vaccine found more effective for elderly

    PITTSBURGH Giving frail, older residents of long-term care facilities a high-dose flu vaccine produces a significantly better immune response than a regular flu shot, a University of Pittsburgh School of Medicine study has found. Published in the Journal...
  • Lawsuit accuses Ackman, Valeant of insider trading in Allergan stock

    Lawsuit accuses Ackman, Valeant of insider trading in Allergan stock
    A new lawsuit accuses hedge fund manager Bill Ackman and Canadian firm Valeant Pharmaceuticals International Inc. of insider trading in Allergan Inc. stock before their unsuccessful bid to acquire the Botox maker. The lawsuit was filed Wednesday on...
  • Few Allergan execs to keep top jobs in Actavis takeover

    Few Allergan execs to keep top jobs in Actavis takeover
    The soon-to-be owner of Irvine-based Allergan Inc. announced sweeping leadership changes that pass over many current executives including the Botox maker's CEO. Irish pharmaceutical giant Actavis expects to finalize its $66-billion acquisition in the...
  • Use these 4 simple strategies to cut your drug spending

    Trying to save money on prescription drugs can be enough to make you reach for the pain pills. Navigating the annual changes to your health plan, figuring out insurance co-pays, and finding the pharmacy with the best buys can be daunting. And if you're on...
  • Merck says patent case won't stop Cubist acquisition

    One day after saying it would spend $9.5 billion to acquire Cubist Pharmaceuticals, Merck & Co., announced that an adverse court decision about key patents for Cubist would not deter it from acquiring the smaller antibiotic drugmaker. Cubist gets about...
  • Karen Hicks: FDA should not approve sex drug for women

    There's yet another pharmaceutical campaign on the offensive, hoping to convince women with sexual problems that a drug called Flibanserin will cure them. This compound is a central nervous system formula originally studied as a remedy for depression....
  • Los Angeles seafood company ordered shut over unsanitary conditions

    A Los Angeles seafood company specializing in smoked and pickled fish was ordered shut by a federal judge over unsanitary conditions. Neptune Manufacturing Inc. can’t reopen until it meets compliance with the U.S. Food and Drug Administration....
  • Dropping coverage of popular prescription drugs is sad and shameful

    Express Scripts, which handles prescription-drug benefits for millions or people nationwide, is dropping coverage for 66 brand-name drugs next month in an effort to keep costs down. Rival CVS Health is dropping 95 drugs from its own list of covered drugs....
  • Special Report: Powerful antibiotic for cows often misused by farmers

    It is one of the most potent antibiotics used by U.S. cattle and dairy farmers, the key component in the top-selling drug line of Zoetis, the world's largest animal health company. But the strength of the antibiotic ceftiofur – and the frequency...